# oncology-provider-profiling-prediction
Machine learning analysis for Oncology provider profiling and prescription prediction

# Oncology Provider Profiling â€“ Machine Learning Analysis

## 1. Overview
Kaggle â€œPrescription-based Predictionâ€ datasetì„ ê¸°ë°˜ìœ¼ë¡œ  
Oncology providerì˜ ì²˜ë°© íŒ¨í„´ì„ ë¶„ì„í•˜ê³  í•­ì•” ì²˜ë°© ì—¬ë¶€ë¥¼ ì˜ˆì¸¡í•˜ëŠ” ë¨¸ì‹ ëŸ¬ë‹ ëª¨ë¸(Logistic Regression ì¤‘ì‹¬)ì„ êµ¬ì¶•í•œ í”„ë¡œì íŠ¸ì…ë‹ˆë‹¤.

ğŸ”¹ êµ°ì§‘(Cluster) ê¸°ë°˜ Provider í”„ë¡œí•„ ìš”ì•½  
ğŸ”¹ í•­ì•” ì²˜ë°© ì—¬ë¶€ ì˜ˆì¸¡(Classification)  
ğŸ”¹ ì „í†µ ML vs. MLP ë¹„êµ

---

## 2. Data Notice
ë³¸ ì €ì¥ì†ŒëŠ” **ì „ì²˜ë¦¬ ì™„ë£Œëœ Provider-level long_df**ë¥¼ ì…ë ¥ ë°ì´í„°ë¡œ ì‚¬ìš©í•©ë‹ˆë‹¤.

ì›ì²œ Kaggle ë°ì´í„°(239,930ëª… â†’ Onco provider í•„í„°ë§ â†’ wide-format â†’ ATC ë§¤í•‘ â†’ long-format ë³€í™˜ ë“± ì „ì²´ ì „ì²˜ë¦¬ ê³¼ì •)ëŠ”  
ìš©ëŸ‰ ë° ë°ì´í„° ê³µìœ  ì œí•œìœ¼ë¡œ ì¸í•´ ì €ì¥ì†Œì—ëŠ” í¬í•¨í•˜ì§€ ì•Šì•˜ìœ¼ë©°,  
**ì „ì²˜ë¦¬ ì „ì²´ ê³¼ì •ì€ ë¶„ì„ ë³´ê³ ì„œì— ìƒì„¸íˆ ê¸°ìˆ ë˜ì–´ ìˆìŠµë‹ˆë‹¤.**

---

## 3. Main Steps
- Data preprocessing (long_df ê¸°ì¤€)
- Clustering (Hellinger + KMeans)
- Statistical testing (Chi-square, ANOVA)
- Feature engineering  
- Classification models (Logistic, RF, XGB, LGBM)
- Deep learning MLP baseline
- Final ROC comparison

---

## 4. Files
- `analysis.ipynb` â€” ì „ì²´ ë¶„ì„ ì½”ë“œ  
- `README.md` â€” í”„ë¡œì íŠ¸ ì„¤ëª…  

---

## 5. Results Summary
- **Logistic Regression: AUC 0.897 (Best ëª¨ë¸)**
- Clusterê°€ Provider í–‰ë™ì„ ê°€ì¥ ì˜ ìš”ì•½í•˜ëŠ” í•µì‹¬ ë³€ìˆ˜ë¡œ í™•ì¸ë¨
- ë”¥ëŸ¬ë‹(MLP)ì€ ì†Œí‘œë³¸Â·ë‹¨ìˆœ tabular í™˜ê²½ì—ì„œ ì„±ëŠ¥ì´ ë‚®ìŒ (AUC 0.42)

---

## 6. Analysis Steps (Details)

### **Step 1. Load Data**
- long_df (Provider Ã— Drug) ê¸°ë°˜ ë°ì´í„° ë¡œë“œ
- Provider-level aggregation êµ¬ì¡° í™•ì¸

### **Step 2. Exploratory Data Analysis**
- ìˆ˜ì¹˜í˜•Â·ë²”ì£¼í˜• ë³€ìˆ˜ ë¶„í¬  
- TAë³„ ì²˜ë°©ëŸ‰ ë° íˆíŠ¸ë§µ ì‹œê°í™”

### **Step 3. Clustering (Hellinger + KMeans)**
- ìƒìœ„ TA ë¹„ì¤‘ ê¸°ë°˜ ë¹„ìœ¨í™”  
- Hellinger ë³€í™˜ í›„ ì •ê·œí™”  
- KMeans(k=6) í´ëŸ¬ìŠ¤í„°ë§  
- t-SNE ì‹œê°í™”

### **Step 4. Cluster Profiling**
- Provider ë©”íƒ€ì •ë³´ ê²°í•©  
- êµ°ì§‘ë³„ TA êµ¬ì„±Â·ì²˜ë°© íŠ¹ì„±Â·ì˜¨ì½” ë¹„ì¤‘ ë¶„ì„

### **Step 5. Feature Engineering**
- onco_rx, onco_share  
- therapy ë¹„ìœ¨  
- brand/generic ì²˜ë°©ëŸ‰  
- ATC3 ë³€ìˆ˜ ìƒì„±  
- ìµœì¢… ëª¨ë¸ ì…ë ¥ í…Œì´ë¸” êµ¬ì„±

### **Step 6. Statistical Testing**
- Chi-square: cluster, gender â†’ y_onco ìœ ì˜  
- ANOVA: tot_rx, onco_share, therapy_pct ìœ ì˜

### **Step 7. Regression Attempt**
- y_L1_total_rx íšŒê·€ ì í•©  
- ì„ í˜•ì„±Â·ì”ì°¨Â·ë‹¤ì¤‘ê³µì„ ì„± ë¬¸ì œ â†’ ë¶„ë¥˜ ëª¨ë¸ë¡œ ì „í™˜

### **Step 8. Classification Models**
- Logistic Regression (Best: AUC 0.897)  
- Random Forest / XGBoost / LightGBM  
- ROC, FN/FP ë¹„êµ

### **Step 9. Deep Learning Baseline (MLP)**
- 2-layer MLP  
- ì†Œí‘œë³¸ ì œí•œìœ¼ë¡œ ê³¼ì í•© ë°œìƒ  
- ROC-AUC 0.42

### **Step 10. Final ROC Comparison**
- Logistic / RF / XGB / LGBM / MLP ROC ë¹„êµ ì‹œê°í™”

---

## 7. Contact
A71039 ì´ê²½ì€  
